-->

Lilly’s new drug may also be used to treat obesity

Post a Comment
The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

Get all the details here > > > 
[ad]
This #1 Stock Under $5

Virginia Stock-Picking Millionaire Says It's Not About Diversification! One single stock under $5 - that trades under a secret name- could help you build your retirement

His details are here. 
[ad]
$200 Oil Sooner Than You Think -- Buy This Now

Are you ready for $200 oil? Analysts believe that we could see oil prices soar past $200 a barrel -- and investors need to get ready. To help people prep their portfolios, Louis Navellier just named his #1 oil stock for 2022.

Get the full story HERE.
 [ad]

UBS analysts have predicted Lilly's obesity drug could generate $25 billion in peak sales if approved, while Morgan Stanley analysts have said the overall market for weight-management drugs could hit $54 billion by 2030.


U.S. District Court Judge Florence Y. Pan announced the decision in a brief statement Monday, adding that much of her ruling remained under seal at the moment because of "confidential information" and "highly confidential information." She asked the two sides to meet with her Friday and suggest redactions.






DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.








2563 cherry hill ln, Hermitage, PA 16148, United States
You may unsubscribe or change your contact details at any time.

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter